ITRM
Price:
$0.44
Market Cap:
$21.14M
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Industry
Biotechnology
IPO Date
2018-05-25
Stock Exchange
NASDAQ
Ticker
ITRM
According to Iterum Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.61. This represents a change of -58.26% compared to the average of -1.46 of the last 4 quarters.
The mean historical PE Ratio of Iterum Therapeutics plc over the last ten years is -23.84. The current -0.61 PE Ratio has changed 155.83% with respect to the historical average. Over the past ten years (40 quarters), ITRM's PE Ratio was at its highest in in the June 2021 quarter at 14.46. The PE Ratio was at its lowest in in the March 2022 quarter at -5.04.
Average
-23.84
Median
-0.70
Minimum
-199.84
Maximum
-0.23
Discovering the peaks and valleys of Iterum Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 896.93%
Maximum Annual PE Ratio = -0.23
Minimum Annual Increase = -98.20%
Minimum Annual PE Ratio = -199.84
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.41 | 111.49% |
| 2023 | -0.67 | 187.67% |
| 2022 | -0.23 | -66.92% |
| 2021 | -0.70 | -89.79% |
| 2020 | -6.85 | 896.93% |
| 2019 | -0.69 | 11.57% |
| 2018 | -0.62 | -82.89% |
| 2017 | -3.60 | -98.20% |
The current PE Ratio of Iterum Therapeutics plc (ITRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.77
5-year avg
-1.97
10-year avg
-23.84
Iterum Therapeutics plc’s PE Ratio is greater than Intensity Therapeutics, Inc. (-1.69), greater than iBio, Inc. (-3.37), greater than Rallybio Corporation (-0.72), greater than Pluri Inc. (-0.87), greater than AN2 Therapeutics, Inc. (-0.86), less than Boundless Bio, Inc. (-0.38), less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), less than TAO Synergies Inc. (-0.37), greater than Q32 Bio Inc. (-1.05), greater than Klotho Neurosciences, Inc. (-2.58),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.69 | $21.70M | |
| -3.37 | $21.16M | |
| -0.72 | $28.16M | |
| -0.87 | $23.49M | |
| -0.86 | $29.18M | |
| -0.38 | $24.62M | |
| -0.37 | $8.43M | |
| -0.37 | $23.26M | |
| -1.05 | $44.54M | |
| -2.58 | $25.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iterum Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Iterum Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Iterum Therapeutics plc's PE Ratio?
How is the PE Ratio calculated for Iterum Therapeutics plc (ITRM)?
What is the highest PE Ratio for Iterum Therapeutics plc (ITRM)?
What is the 3-year average PE Ratio for Iterum Therapeutics plc (ITRM)?
What is the 5-year average PE Ratio for Iterum Therapeutics plc (ITRM)?
How does the current PE Ratio for Iterum Therapeutics plc (ITRM) compare to its historical average?